The European Health Data Space (EHDS) will help researchers use health data across EU Member States (MS). Currently, cross-border research faces heterogeneous data access processes. Using a real-world use case, this paper analyses challenges and opportunities brought by the upcoming implementation of the EHDS, assessing the situation before and after the regulation comes into force. The use case focused on metastatic colorectal cancer, analysing the relations between mutational signatures and clinical trajectories while addressing data access procedures across MS. The regulatory landscape and the challenges that need to be addressed for the EHDS to enable the secondary use of health data, particularly genomic data, are complex and heterogeneous across MS. We describe the pathway from data application to access to pseudonymized data in secure processing environments, emphasizing the legal requirements, including the role of ethics committees. Finally, we analyse the success factors for achieving access to the data and the reasons for access denial to support shaping the upcoming EHDS implementation. Several challenges remain unaddressed for cross-border data use, especially in the context of genomic data, where the complexity and heterogeneity of informed consent can impact or even impede data-sharing efforts. While EHDS can simplify processes across MS, it is crucial to ensure that additional safeguards do not negatively impact or block access to health data and that EHDS infrastructure is ready for effective and affordable processing of large volumes of genomic and other data.

BBMRI ERIC Graz Austria

Catalan Institution for Research and Advanced Studies Barcelona Spain

CONNECT Center for Clinical and Genomic Data Aarhus University Hospital Aarhus N Central Denmark Region Denmark

Department of Clinical Epidemiology Aarhus University Hospital and Aarhus University Aarhus N Denmark

ELIXIR Hub Wellcome Genome Campus Cambridge United Kingdom

Institute of Computer Science Masaryk University Brno Czechia

Life Sciences Department Barcelona Supercomputing Center Barcelona Spain

Norwegian Institute of Public Health Health Data Service Tynset Norway

Oslo University Hospital Institute of Cancer Research Oslo Norway

Sciensano Cancer Centre Brussels Belgium

TMF Technologie und Methodenplattform für die vernetzte medizinische Forschung e 5 Berlin Germany

Zobrazit více v PubMed

Hussein R, Balaur I, Burmann A  et al.  Getting ready for the European Health Data Space (EHDS): IDERHA’s plan to align with the latest EHDS requirements for the secondary use of health data. Open Res Eur  2024;4:160. PubMed PMC

Alexandrov LB, Kim J, Haradhvala NJ  et al. , PCAWG Consortium. The repertoire of mutational signatures in human cancer. Nature  2020;578:94–101. https://www.nature.com/articles/s41586-020-1943-3 PubMed PMC

Rulten SL, Grose RP, Gatz SA, Jones JL, Cameron AJM.  The future of precision oncology. Int J Mol Sci  2023;24(16):12613. https://www.mdpi.com/1422-0067/24/16/12613/htm PubMed PMC

Allam M, Cai S, Coskun AF.  Multiplex bioimaging of single-cell spatial profiles for precision cancer diagnostics and therapeutics. NPJ Precis Oncol  2020;4:1–14. https://www.nature.com/articles/s41698-020-0114-1 PubMed PMC

Martyn M, Forbes E, Lee L  et al.  Secondary use of genomic data: patients’ decisions at point of testing and perspectives to inform international data sharing. Eur J Hum Genet  2024;32:717–24. https://www.nature.com/articles/s41431-023-01531-5 PubMed PMC

Loane M, Loane M, Garne E  et al.  Building public trust and confidence in secondary use of health data in Ireland. Eur J Public Health  2023;33. 10.1093/eurpub/ckad160.302 DOI

Long D, Mao C, Zhang Z  et al.  Long-term trends in the burden of colorectal cancer in Europe over three decades: a joinpoint regression and age-period-cohort analysis. Front Oncol  2023;13:1287653. PubMed PMC

Tjota MY, Segal JP, Wang P.  Clinical utility and benefits of comprehensive genomic profiling in cancer. J Appl Lab Med  2024;9:76–91. 10.1093/jalm/jfad091 PubMed DOI

van Putten J., Koster R., Snaebjornsson P., et al.  1249P whole genome sequencing-based cancer diagnostics in routine clinical practice: an interim analysis of two years of real-world data. Ann Oncol. 2023;34:S727. http://www.annalsofoncology.org/article/S0923753423031757/fulltext

Nakken S, Fournous G, Vodák D  et al.  Personal cancer genome reporter: variant interpretation report for precision oncology. Bioinformatics  2018;34:1778–80. 10.1093/bioinformatics/btx817 PubMed DOI PMC

VCFv, BCFv.

Laugesen K, Mengel-From J, Christensen K  et al.  A review of major danish biobanks: advantages and possibilities of health research in Denmark. Clin Epidemiol  2023;15:213–39. PubMed PMC

Home | Danish Research Ethics Committees. https://researchethics.dk/ (23 October 2004, date last accessed).

Umar A, Boland CR, Terdiman JP  et al.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst  2004;96:261–8. 10.1093/jnci/djh034 PubMed DOI PMC

BBMRI-ERIC.

BBMRI-ERIC.

Reihs R, Proynova R, Maqsood S  et al.  BBMRI-ERIC negotiator: implementing efficient access to biobanks. Biopreserv Biobank  2021;19:414–21. https://pubmed.ncbi.nlm.nih.gov/34182766/ PubMed

Brlek Petar, Bulić Luka, Bračić Matea, et al.  Implementing whole genome sequencing (WGS) in clinical practice: advantages, challenges, and future perspectives. Cells  2024;13(6):504. https://www.mdpi.com/2073-4409/13/6/504/htm PubMed PMC

Bagger FO, Borgwardt L, Jespersen AS  et al.  Whole genome sequencing in clinical practice. BMC Med Genomics  2024;17:39–16. https://bmcmedgenomics.biomedcentral.com/articles/10.1186/s12920-024-01795-w PubMed DOI PMC

Tumor-only sequencing has limitations. Cancer Discov. 2015;5:OF17. https://aacrjournals.org/cancerdiscovery/article/5/7/OF17/5149/Tumor-Only-Sequencing-Has-LimitationsTumor-Only PubMed

Green RC, Berg JS, Grody WW, et al. , American College of Medical Genetics and Genomics. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med  2013;15:565–74. https://pubmed.ncbi.nlm.nih.gov/23788249/ PubMed PMC

Raab R, Küderle A, Zakreuskaya A  et al.  Federated electronic health records for the European Health Data Space. Lancet Digit Health  2023;5:e840–7–e847. PubMed

Regulation-EU-2025/327-EN-EUR-Lex. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L_202500327